BDBM220129 US20240317756, Compound 18::US9278100, 18

SMILES CN(C)C/C=C/C(=O)NC1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1

InChI Key InChIKey=SYFFKWAKQHJCOM-UHFFFAOYSA-N

Data  10 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 220129   

TargetTyrosine-protein kinase Lck(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 220129BDBM220129(US9278100, 18 | US20240317756, Compound 18)
Affinity DataIC50: 0.760nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction condition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2017
Entry Details
US Patent

TargetTyrosine-protein kinase Lck(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 220129BDBM220129(US9278100, 18 | US20240317756, Compound 18)
Affinity DataIC50: 0.760nMAssay Description:For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 220129BDBM220129(US9278100, 18 | US20240317756, Compound 18)
Affinity DataIC50: 1.38nMAssay Description:For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 220129BDBM220129(US9278100, 18 | US20240317756, Compound 18)
Affinity DataIC50: 1.38nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction condition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2017
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 220129BDBM220129(US9278100, 18 | US20240317756, Compound 18)
Affinity DataIC50: 22.5nMAssay Description:For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 220129BDBM220129(US9278100, 18 | US20240317756, Compound 18)
Affinity DataIC50: 22.5nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction condition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2017
Entry Details
US Patent

TargetTyrosine-protein kinase ITK/TSK(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 220129BDBM220129(US9278100, 18 | US20240317756, Compound 18)
Affinity DataIC50: 2.54E+3nMAssay Description:For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetTyrosine-protein kinase ITK/TSK(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 220129BDBM220129(US9278100, 18 | US20240317756, Compound 18)
Affinity DataIC50: 2.54E+3nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction condition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2017
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 220129BDBM220129(US9278100, 18 | US20240317756, Compound 18)
Affinity DataIC50: 1.00E+4nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction condition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2017
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 220129BDBM220129(US9278100, 18 | US20240317756, Compound 18)
Affinity DataIC50: 1.00E+4nMAssay Description:For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent